![Ron Tilles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ron Tilles
Vorstandsvorsitzender bei Vyera Pharmaceuticals LLC
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Milind Tavshikar | M | - |
QuantumID Technologies, Inc.
![]() QuantumID Technologies, Inc. Packaged SoftwareTechnology Services QuantumID Technologies, Inc. provides radio frequency identification software. It helps businesses and governments to deploy secure, scalable and affordable monitoring and management solutions. The company was founded in 2005 and is headquartered in Cambridge, MA. | 19 Jahre |
Prasanna Gogwekar | M | - |
QuantumID Technologies, Inc.
![]() QuantumID Technologies, Inc. Packaged SoftwareTechnology Services QuantumID Technologies, Inc. provides radio frequency identification software. It helps businesses and governments to deploy secure, scalable and affordable monitoring and management solutions. The company was founded in 2005 and is headquartered in Cambridge, MA. | - |
Brian Shortsleeve | M | - |
QuantumID Technologies, Inc.
![]() QuantumID Technologies, Inc. Packaged SoftwareTechnology Services QuantumID Technologies, Inc. provides radio frequency identification software. It helps businesses and governments to deploy secure, scalable and affordable monitoring and management solutions. The company was founded in 2005 and is headquartered in Cambridge, MA. | 3 Jahre |
Christopher Cheever | M | - |
QuantumID Technologies, Inc.
![]() QuantumID Technologies, Inc. Packaged SoftwareTechnology Services QuantumID Technologies, Inc. provides radio frequency identification software. It helps businesses and governments to deploy secure, scalable and affordable monitoring and management solutions. The company was founded in 2005 and is headquartered in Cambridge, MA. | - |
Nancy Retzlaff | F | - |
Vyera Pharmaceuticals LLC
![]() Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 5 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ron Tilles
- Persönliches Netzwerk